Fresenius Medical Care recently accelerated the second tranche of its €1.00 billion share buyback program, committing about €415 million to repurchases between January and May 2026 as part of its FME ...
Fresenius Medical Care (XTRA:FME) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months, alongside positive ...
Fresenius Medical Care invests EUR 312 million and successfully closes a share purchase agreement with all non-physician investors in Interwell Health (IWH), accelerating the timeline originally set ...
Fresenius Medical Care FMS recently unveiled its forward-looking “FME Reignite” strategy at the 2025 Capital Markets Day, aiming to achieve industry-leading profitability while optimizing capital ...